Cargando…
Efficacy of remimazolam versus midazolam for procedural sedation: post hoc integrated analyses of three phase 3 clinical trials
Background and study aims Remimazolam is an ultra-short acting, fast onset/fast offset benzodiazepine for intravenous use in procedural sedation, general anesthesia, and Intensive Care Unit sedation. The aim of this work was to compare the efficacy of remimazolam versus midazolam dosed according to...
Autores principales: | Dao, Van-Anh, Schippers, Frank, Stöhr, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Georg Thieme Verlag KG
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9010109/ https://www.ncbi.nlm.nih.gov/pubmed/35433203 http://dx.doi.org/10.1055/a-1743-1936 |
Ejemplares similares
-
Population Pharmacokinetics of Remimazolam in Procedural Sedation With Nonhomogeneously Mixed Arterial and Venous Concentrations
por: Zhou, Jie, et al.
Publicado: (2020) -
A population pharmacodynamic Markov mixed‐effects model for determining remimazolam‐induced sedation when co‐administered with fentanyl in procedural sedation
por: Zhou, Jie, et al.
Publicado: (2021) -
The comparison of remimazolam and midazolam for the sedation of gastrointestinal endoscopy: a meta-analysis of randomized controlled studies
por: Zhang, Lin, et al.
Publicado: (2022) -
Remimazolam versus propofol for procedural sedation: a meta-analysis of randomized controlled trials
por: Chang, Yu, et al.
Publicado: (2023) -
Randomized Crossover Trial to Compare Abuse Liability of Intravenous Remimazolam Versus Intravenous Midazolam and Placebo in Recreational Central Nervous System Depressant Users
por: Schippers, Frank, et al.
Publicado: (2020)